Freimuth Robert R, Wix Kelly, Zhu Qian, Siska Mark, Chute Christopher G
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Rochester, MN ; Office of Information and Knowledge Management, Rochester, MN.
Pharmacy Services Information Systems; Mayo Clinic, Rochester, MN.
AMIA Annu Symp Proc. 2014 Nov 14;2014:554-63. eCollection 2014.
We evaluated the potential use of RxNorm to provide standardized representations of generic drug name and route of administration to facilitate management of drug lists for clinical decision support (CDS) rules. We found a clear representation of generic drug name but not route of administration. We identified several issues related to data quality, including erroneous or missing defined relationships, and the use of different concept hierarchies to represent the same drug. More importantly, we found extensive semantic precoordination of orthogonal concepts related to route and dose form, which would complicate the use of RxNorm for drug-based CDS. This study demonstrated that while RxNorm is a valuable resource for the standardization of medications used in clinical practice, additional work is required to enhance the terminology so that it can support expanded use cases, such as managing drug lists for CDS.
我们评估了使用RxNorm提供通用药物名称和给药途径的标准化表示形式的可能性,以促进临床决策支持(CDS)规则的药物列表管理。我们发现通用药物名称有清晰的表示形式,但给药途径却没有。我们识别出了几个与数据质量相关的问题,包括错误或缺失的定义关系,以及使用不同的概念层次结构来表示同一药物。更重要的是,我们发现与给药途径和剂型相关的正交概念存在广泛的语义预协调,这会使将RxNorm用于基于药物的CDS变得复杂。这项研究表明,虽然RxNorm是临床实践中药物标准化的宝贵资源,但仍需要额外的工作来改进术语,以便它能够支持更多扩展用例,例如管理用于CDS的药物列表。